Context Therapeutics Inc.
CNTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001842952
No open-market purchases or sales by Context Therapeutics Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $34.8M in total; no superinvestor holds it.
Holders of 5% or more of CNTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Context Therapeutics Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Avidity Partners Management LP | 13G/A | 8.70%8.30M shares | −1.20 ppfrom 9.90% | Feb 14, 20254 filings | May 12, 2026 | SEC |
| Deep Track Capital, LP | 13G/A | 8.27%7.42M shares | – | May 15, 20251 filing | May 15, 2025 | SEC |
| Soleus Capital Master Fund, L.P. | 13G/A | 7.60%6.96M shares | +2.40 ppfrom 5.20% | Feb 3, 20262 filings | May 8, 2026 | SEC |
| BlackRock, Inc. | 13G | 6.70%6.17M shares | New | Jul 27, 20261 filing | Jul 27, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
26 Schedule 13D and 13G filings on Context Therapeutics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20264:03 PM ET | MPM Oncology Impact Management LP | 13G/A | 1.40%1.30M shares | −10.20 ppfrom 11.60%Below 5% | Jun 30, 2026 | SEC |
| Aug 12, 20264:30 PM ET | Blue Owl Capital Holdings LP | 13G/A | 3.19%2.93M shares | −2.35 ppfrom 5.54%Below 5% | Jun 30, 2026 | SEC |
| Jul 31, 20264:01 PM ET | Octagon Capital Advisors LPand 2 others | 13G/A | 3.30%3.05M shares | −2.40 ppfrom 5.70%Below 5% | Jun 30, 2026 | SEC |
| Jul 27, 20264:25 PM ET | BlackRock, Inc. | 13G | 6.70%6.17M shares | New | Jun 30, 2026 | SEC |
| May 15, 20268:55 AM ET | Great Point Partners LLCand 2 others | 13G/A | 2.44%2.24M shares | −2.66 ppfrom 5.10%Below 5% | Mar 31, 2026 | SEC |
| May 14, 20264:20 PM ET | Blue Owl Capital Holdings LP | 13G/A | 5.54%5.09M shares | −2.94 ppfrom 8.48% | Mar 31, 2026 | SEC |
| May 14, 20264:01 PM ET | Octagon Capital Advisors LPand 2 others | 13G | 5.70%5.25M shares | New | Mar 31, 2026 | SEC |
| May 12, 20263:07 PM ET | Avidity Partners Management LPand 5 others | 13G/A | 8.70%8.30M shares | −1.20 ppfrom 9.90% | Mar 31, 2026 | SEC |
| May 8, 20265:00 PM ET | Soleus Capital Master Fund, L.P.and 5 others | 13G/A | 7.60%6.96M shares | +2.40 ppfrom 5.20% | Mar 31, 2026 | SEC |
| Feb 17, 20264:17 PM ET | Great Point Partners LLCand 2 others | 13G/A | 5.10%4.68M shares | −0.12 ppfrom 5.22% | Dec 31, 2025 | SEC |
| Feb 17, 20264:09 PM ET | MPM Oncology Impact Management LP | 13G/A | 11.60%10.7M shares | −4.80 ppfrom 16.40% | Dec 31, 2025 | SEC |
| Feb 3, 20264:41 PM ET | Soleus Capital Master Fund, L.P.and 5 others | 13G | 5.20%4.78M shares | New | Feb 2, 2026 | SEC |
| Nov 14, 20254:27 PM ET | Avidity Partners Management LPand 7 others | 13G/A | 9.90%9.20M shares | 0.00 ppfrom 9.90% | Sep 30, 2025 | SEC |
| Nov 14, 20251:16 PM ET | Great Point Partners LLCand 2 others | 13G/A | 5.22%4.68M shares | 0.00 ppfrom 5.22% | Sep 30, 2025 | SEC |
| Aug 14, 20255:11 PM ET | Great Point Partners LLCand 2 others | 13G/A | 5.22%4.68M shares | 0.00 ppfrom 5.22% | Jun 30, 2025 | SEC |
| Aug 14, 20252:28 PM ET | Avidity Partners Management LPand 6 others | 13G/A | 9.90%9.13M shares | 0.00 ppfrom 9.90% | Jun 30, 2025 | SEC |
| May 15, 20254:44 PM ET | Great Point Partners LLCand 2 others | 13G/A | 5.22%4.68M shares | −1.03 ppfrom 6.25% | Mar 31, 2025 | SEC |
| May 15, 20258:38 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 8.27%7.42M shares | – | Mar 31, 2025 | SEC |
| May 9, 20251:08 PM ET | Franklin Resources Incand 2 others | 13G/A | 4.50%4.00M shares | −0.80 ppfrom 5.30%Below 5% | Mar 31, 2025 | SEC |
| Feb 14, 20255:09 PM ET | Blue Owl Capital Holdings LP | 13G/A | 8.48%6.36M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 20254:33 PM ET | Great Point Partners LLCand 2 others | 13G/A | 6.25%4.68M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 202510:02 AM ET | Avidity Partners Management LPand 7 others | 13G/A | 9.90%7.78M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 20256:27 AM ET | Opaleye Management Inc. | 13G/A | 0.00%0 shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 12, 20255:20 PM ET | Lehr Martin A.and 2 others | 13G/A | 2.10%1.60M shares | –Below 5% | Dec 31, 2024 | SEC |
| Jan 27, 202512:55 PM ET | Franklin Resources Incand 3 others | 13G | 5.30%4.00M shares | New | Dec 31, 2024 | SEC |
| Jan 8, 20254:07 PM ET | MPM Oncology Impact Management LP | 13G | 16.40%14.7M shares | New | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Context Therapeutics Inc. shares.
No Form 144 notices for Context Therapeutics Inc. are on file.